Recursion Pharmaceuticals, Inc. has grown revenue 13% a year over three years and 59% a year over five. Revenue growth, 3-year annual rate: +13% (Biotechnology median +21%). Revenue growth, 5-year rate: +59%, growth has slowed since the five-year average. Years of annual history on file: 7, FY2019 to FY2025, as filed.

RXRXRecursion Pharmaceuticals, Inc.

HealthcareUSD

$3.48

$2.8452 weeks$6.79

Is it growing?

Is RXRX growing?

Recursion Pharmaceuticals, Inc. has grown revenue 13% a year over three years and 59% a year over five.

+13%

Revenue growth, 3-year annual rate · Biotechnology median +21% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +59%
Revenue growth, 5-year rate · +13% over three · growth has slowed since the five-year average
Years of annual history on file: 7
Years of annual history on file · FY2019 to FY2025, as filed

Details›